SEMAGLUTIDE

Description

SEMAGLUTIDE is a long-acting GLP-1 receptor agonist used for type 2 diabetes and obesity. Enhances insulin secretion, reduces appetite, and slows gastric emptying. Marketed as Ozempic and Wegovy.

Additional Information:
Dose: 5 mg
Third- party tested
Made in Canada 

Endorsed by Dr Sanjeev Goel – Canada’s Longevity MD.  We believe in providing the highest quality peptides backed by science.